3rd Circ. Affirms Win For GSK In Wellbutrin Antitrust Case
The Third Circuit ruled on Wednesday not to revive a class action lawsuit accusing GlaxoSmithKline PLC of violating antitrust laws with an alleged pay-for-delay settlement with would-be generic manufacturers for the...To view the full article, register now.
Already a subscriber? Click here to view full article